47 Experts from 23 countries took part in the Meeting, during which we summarized last 12 months and hitherto achievements (for last 9 years it is 105 papers cited almost 5000 times), and we discussed the papers we have just started with the detailed timelines for them to be released. Taking this opportunity I would […]

The 2nd meeting of the International Lipid Expert Panel (ILEP) was finished❗ For me personally it was one of the most important meeting in last many years. Finally I was able to invite and to host in my native Lodz 20 Polish and International hasztag#ILEP Experts from Slovakia, Czechia, Greece, Croatia, Latvia, UK, Israel, and […]

Dear Colleagues and Friends, We kindly invite you to complete a short questionnaire on knowledge about inflammation as a risk factor for cardiovascular diseases, on possible diagnosis, and management in the context of residual cardiovascular risk.https://ptlipid.pl/ankiety/how-important-is-inflammation-as-a-residual-cardiovascular-risk-factor-the-knowledge-perception-and-management/ The results of the questionnaire will help in planning educational activities and preparing a short, very practical Expert Document […]

The Baltic – Ukrainian Atherosclerosis Conference will be held in hybrid format in Tallinn on 10.11.2023 at Hilton Tallinn Park Hotel (Fr. R. Kreutzwaldi 23), event will be preceded by Conference pre-session „Familial hypercholesterolemia round-table” on 09.11.23 (same venue). Click baner to see more!

We are so happy to announce that Professor Dimitri P. Mikhailidis from the UCL has received the first ILEP Honorary Membership Award. Thank you to all of you for the unanimous support of this award to Professor Mikhailidis.  And it is not only related to the fact that prof. Mikhailidis was a co-founder of the […]

In our next meta-analysis (the largest in the world) we showed a significant inverse association between daily step count and all-cause mortality and CV mortality with more the better over the cut-off point of 3867 steps/day for all-cause mortality and only 2337 steps for CV mortality. This confirms that we can start even with the […]

Within the group of the recognized Polish experts, based on the data from the PL-ACS Registry, for the first time in the world we confirmed that the upfront combination lipid-lowering therapy is superior to statin monotherapy for all-cause mortality in patients with ACS. These results suggest that in high-risk patients, such an approach, rather than […]

Within LBPMC Group we also evaluated the relationship between electronic nicotine delivery systems (ENDS) use and the risk of stroke when compared to non-smokers. The results were presented at the ESC Congress in Amsterdam and published simultaneously in the Archives of Medical Science.  https://www.archivesofmedicalscience.com/Association-between-electronic-nicotine-delivery-systems-use-and-risk-of-stroke-a,171473,0,2.html 

Please see the most recent ILEP expert opinion paper, just published in the European Heart Journal, on the role of low carbohydrate diet/ketogenic diet on the concentration and management of evaluated lipoprotein(a) level. – https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad635/7285571?login=false 

Statins are a widely available, cheap, safe, and extremely effective means to reduce the cardiovascular disease (CVD) risk, and it is therefore a tragedy that these life-saving medicines are under-used. Non-adherence to statin therapy reaches up to 60% after 2 years, and cessation is associated with a significant increase in the risk of CVD events. Much of this […]